Welcome to LookChem.com Sign In|Join Free

CAS

  • or

850449-93-3

Post Buying Request

850449-93-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

850449-93-3 Usage

Description

METHYL 2-(5-AMINO-2-METHYLPHENYL)ACETATE, with the molecular formula C10H13NO2, is a methyl ester derivative of 5-amino-2-methylphenylacetic acid. It is a chemical compound that serves as an intermediate in the synthesis of pharmaceuticals and organic compounds. Its potential applications in medicinal chemistry and drug discovery are attributed to its ability to modify the bioactivity of certain molecules. Due to its potential health and safety risks, it is crucial to handle and store METHYL 2-(5-AMINO-2-METHYLPHENYL)ACETATE with care.

Uses

Used in Pharmaceutical Industry:
METHYL 2-(5-AMINO-2-METHYLPHENYL)ACETATE is used as a chemical intermediate for the synthesis of various pharmaceuticals and organic compounds. Its role in modifying the bioactivity of certain molecules makes it a valuable component in the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, METHYL 2-(5-AMINO-2-METHYLPHENYL)ACETATE is utilized as a key building block in the design and synthesis of novel compounds with potential therapeutic properties. Its ability to alter the bioactivity of molecules contributes to the discovery of new drugs and the improvement of existing ones.
Used in Drug Discovery:
METHYL 2-(5-AMINO-2-METHYLPHENYL)ACETATE plays a significant role in drug discovery, where it is employed to explore and develop new chemical entities with potential medicinal applications. Its versatility in modifying the bioactivity of molecules aids researchers in identifying and optimizing drug candidates for various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 850449-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,4,4 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 850449-93:
(8*8)+(7*5)+(6*0)+(5*4)+(4*4)+(3*9)+(2*9)+(1*3)=183
183 % 10 = 3
So 850449-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2/c1-7-3-4-9(11)5-8(7)6-10(12)13-2/h3-5H,6,11H2,1-2H3

850449-93-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(5-amino-2-methylphenyl)acetate

1.2 Other means of identification

Product number -
Other names 2-(5-amino-2-methyl-phenyl)-acetic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:850449-93-3 SDS

850449-93-3Relevant articles and documents

(PYRIDIN-2-YL)AMINE DERIVATIVES AS TGF-BETA R1 (ALK5) INHIBITORS FOR THE TREATMENT OF CANCER

-

Paragraph 00357, (2020/07/15)

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder associated with ΤGFβR1 activity, such as a cancer or fibrosis. The invention provides compounds of Formula (I) and Formula (II) as further described herein having an acidic moiety that enhances tissue specificity for targeted tissues and organs. The invention includes pharmaceutical compositions, pharmaceutical combinations, and methods of use of these compounds for treating conditions including cancer or fibrosis.

RORGAMMA MODULATORS AND USES THEREOF

-

Page/Page column 41; 42, (2018/08/20)

The present invention provides novel compounds of formula (la) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases, or cholestatic diseases.

COMPOSITIONS AND METHODS FOR MODULATING C-KIT AND PDGFR RECEPTORS

-

Page/Page column 33; 34, (2008/12/05)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit, PDGFR , PDGFR , CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGF , SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2 , BRK, KDR, c-raf or b-raf kinase, or mutant forms thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 850449-93-3